Effect of MUSK Pill on the Patients With Chest Pain Due to Non Obstructive Coronary Artery Disease
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled clinical trial. Patients
were treated with the trial drug or placebo in a 1:1 ratio. The control group was treated
with placebo 4 pills / day, 3 times / day on the basis of conventional treatment until the
end of follow-up, while the experimental group was treated with MUSK Pill 4 pills / day, 3
times / day on the basis of conventional treatment until the end of follow-up.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Hutchison Pharmaceuticals Limited
Collaborators:
Jinshan Hospital Fudan University Shanghai Changzheng Hospital Shanghai University of Traditional Chinese Medicine